Cargando…
Overcoming therapeutic resistance to platinum-based drugs by targeting Epithelial–Mesenchymal transition
Platinum-based drugs (PBDs), including cisplatin, carboplatin, and oxaliplatin, have been widely used in clinical practice as mainstay treatments for various types of cancer. Although there is firm evidence of notable achievements with PBDs in the management of cancers, the acquisition of resistance...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614084/ https://www.ncbi.nlm.nih.gov/pubmed/36313710 http://dx.doi.org/10.3389/fonc.2022.1008027 |